[1] GoelV,HogadeSA,KaradesaiSG, 2012.Ventilator associated pneumonia in a medical intensive care unit: Microbial etiology, susceptibility patterns of isolated microorganisms and outcome,Indian J Anaesth 56 558 -62
[2] MelsenWG,RoversMM,GroenwoldRH,BergmansDC,CamusC,BauerTT, 2013.Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies,Lancet Infect Dis 13 665 -71
[3] MichettiCP,AldaghlasT., 2012.Differences in management and mortality with a bronchoalveolar lavage-based diagnostic protocol for ventilator-associated pneumonia,J Trauma Acute Care Surg 72 242 -46
[4] RogersAD,ArgentAC,RodeH, 2012.Ventilator associated pneumonia in major burns,Ann Burns Fire Disasters 25 135 -9
[5] CernadaM,BrugadaM,GolombekS,VentoM., 2014.Ventilatorassociated pneumonia in neonatal patients: An update,Neonatology 105 98 -107
[6] AgrafiotisM,SiemposII,NtaidouTK,FalagasME, 2011.Attributable mortality of ventilator-associated pneumonia: A meta-analysis,Int J Tuber Lung D 15 1154 -63
[7] MathaiaAS,PhillipsA,KaurP,IsaacR, 2014.Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India,J Infect Public Health 13 114 -21
[8] GrapMJ,MunroCL,UnokiT,HamiltonVA,WardKR, 2012.Ventilator-associated pneumonia: the potential critical role of emergency medicine in prevention,J Emerg Med 42 353 -62
[9] ZolfaghariPS,WyncollDL, 2011.The tracheal tube, gateway to ventilator-associated pneumonia,J Crit Care Med 15 310 -17
[10] 2015.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twenty first informational supplements M100-S21, -
[11] GrgurichPE,HudcovaJ,LeiY,SarwarA,CravenDE, 2013.Diagnosis of ventilator-associated pneumonia, controversies and working toward a gold standard,Curr Opin Infect Dis 26 140 -50
[12] ZhangDS,ChenC,ZhouWV, 2012.Ventilator associated pneumonia in major burns,Ann Burns Fire Disasters 25 135 -9
[13] RosenthalVD,RodriguesC,Alvarez-MorenoC,MadaniN,MitrevZ,YeG, 2012.Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: Findings of the International Nosocomial Infection Control Consortium,Crit Care Med 40 3121 -8
[14] ChiSY,KimTO,ParkCW,YuJY,LeeB,LeeHS, 2012.Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital,Tuberc Respir Dis 73 32 -7
[15] ChittawatanaratK,JaipakdeeW,ChotirosniramitN,ChandachamK,JirapongcharoenlapT, 2014.resistance patterns and risk factors for mortality in ventilator associated bacterial pneumonia in northern Thai tertiary care university based general surgical intensive care unit,Infect Drug Resis 7 203 -10
[16] ArthurLE,KizorRS,SelimAG,Van DrielML,SeoaneL, 2016.Antibiotics for ventilator associated pneumonia,Cochrane Database Syst Rev 20 10 -24
[17] WilkeM,GrubeR., 2013.Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: Review of actual guidelines and economic aspects of therapy,Infect Drug Resist 7 1 -7
[18] VienLM,NguyenTK,VoongVP,CorinneT,NguyenPH,TranVT, 2015.In vitro activity of colistin in antimicrobial combination against carbapenem resistant acinetobcacter baumanii isolated from patients with ventilator associated pneumonia in Vietnam,J Med Microbiology 64 1162 -69
[19] ZaltsR,NeubergerA,HusseinK,Raz-PasteurA,GeffenY,MashiachT, 2016.Treatment of carbapenem resistant Acinetobacter baumanii ventilator associated pneumonia: Retrospective comparison between intravenous colistin and intravenous Ampicillin-sulbactam,American J of Therapeutics 23 78 -85